Market Research Hub

Global in Vitro Diagnostics Quality Control Market Expected to Offer Growth at 3.3% CAGR During the Forecast Period 2017 - 2022

The North America market for in vitro diagnostics quality controls is expected to rise from US$262.8 mn in 2017 to US$311.7 mn by the end of 2022.


Albany, NY -- (SBWIRE) -- 11/24/2017 -- Vitro diagnostics refers to a diverse range of medical and veterinary laboratory tests which are used to analyze diseases as well as monitor clinical status of patients with the help of samples of cells, blood, or other tissues. It has been studied that, the market for vitro diagnostics is expected to boost over the coming years. This growth trend has been analyzed through a smart report titled "In Vitro Diagnostics Quality Control Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 – 2022", added to the huge repository managed at Market Research Hub (MRH). This report analyzes the 2012-2017 growth statistics of the global in vitro diagnostics quality control market so as to update the readers with a precise picture regarding the historical growth trajectory along with factors responsible for this positive phase.

Request Free Sample Report:

As per active research findings, the global in vitro diagnostics quality control market is expected to be valued at US$710.8 mn in 2017 (end). Further, the analysts estimate the market to surge to US$837 mn by the end of 2022. At this pace, the concerned market is projected to highlight a steady 3.3% CAGR during the forecast period, 2017-2022.

The report starts with the executive summary followed by the market overview associated to the global in vitro diagnostics quality control market. Readers can gain access to useful data such as market dynamics together with supply chain, cost structure and pricing analysis. A precise study over the key drivers and restraints is presented in this research report. The affecting nature of these factors on the global in vitro diagnostics quality control market is accessed in-depth to enlighten the readers with a transparent picture.

The following section of the report targets the segmentation of the global in vitro diagnostics quality control market based on product type. It includes whole blood based controls, urine based controls, data management solutions, serum/plasma based controls and quality assurance services. Further, bifurcation of the market based on end use covers hospitals, research and academic institutes, clinical laboratories, and others. In the present time, the key applications associated with in vitro diagnostics quality control focuses on immunochemistry, hematology, molecular diagnostics, clinical chemistry, microbiology, and others.

Browse Full Report with TOC-

At last, the report offers a meticulous analysis about the key players from the target sector. Abbott Laboratories, Helena Laboratories, Bio-Rad Laboratories Inc., Ortho Clinical Diagnostics Inc., Roche Diagnostics, Seracare Life Sciences Inc., Randox Laboratories Ltd., Siemens Healthineers, Sun Diagnostics LLC, Sysmex Corporation, Thermo Fisher Scientific Inc. and Quantimetrix Corporation, are some of the prime leaders from the global in vitro diagnostics quality control market.

Enquire about this Report-

About Market Research Hub
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH's expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Contact Us
90 State Street,
Albany, NY 12207,
United States
Toll Free : 800-998-4852 (US-Canada)
Email :
Website :
Read Industry News at -